课题基金 / 基金详情

High throughput intermediate scale sequencing for the Midlands

High throughput intermediate scale sequencing for the Midlands
中部地区高通量中规模测序
批准号:
BB/M012336/1
负责人:
Matthew Loose
金额:
$35.7万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --

项目摘要

项目成果

Matthew Loose的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Since the advent of sequencing, driven by Frederick Sanger, the knowledge of the underlying genetic code of an organism has been a key feature in establishing the mechanisms by which inheritance influences phenotype. The rapid explosion in next generation sequencing technology in the past decade has taken us from huge consortia trying to determine the sequence of a single human genome to individuals being able to sequence their own genomes for close to $1,000. Alongside the sequencing of the genomic DNA it is also possible to sequence the transcriptome (genes expressed in a cell or tissue) or investigate modifications to the bases of DNA that alter the expression of genes. Researchers at the University of Nottingham have used NGS to investigate changes in the copy number of sequences within the genome and even used NGS to investigate how genomes are copied during bacterial replication.Although the UoN has a range of sequencing technologies available, there is a clear gap at two levels of sequencing that are addressed by this proposal. Current technologies available at UoN allow sequencing at the level of individual microbial genomes or targeted sequencing of small regions of the human genome. These scales preclude the use of NGS to study diverse organisms with larger genomes where many of the techniques developed for studying well-characterised genomes can be readily applied. At the opposite scale, whole genome sequencing (WGS) of small genomes can be of enormous importance when carrying out both targeted and random mutagenesis experiments to engineer new phenotypes (synthetic biology). Here the generation of compensatory or off target mutants is a risk and so routine WGS can be applied to screen against such events. At this scale, the labour costs associated with library preparation limit the cost effectiveness of these approaches.To address these issues we seek to purchase a NextSeq500 sequencer (Illumina) alongside a BioMEK 4000 liquid handling robot that will be capable of preparing 24 independent libraries for sequencing at any one time. The NextSeq technology can theoretically sequence 96 libraries in a single run enabling cost effective high throughput sequencing of multiple bacterial genomes simultaneously. The BioMEK 4000 can also be used to prepare a wide range of libraries suitable for sequencing drastically reducing overhead costs to researchers. The cross compatibility of libraries generated between all the Illumina sequencing platforms will allow DeepSeq to prepare libraries which can be sequenced using capacity at our partner institutions.NGS technologies have a wide range of research questions. The NGS technologies outlined here will greatly enhance research at the UoN in a broad range of fields. Some of these fields include: (i) Synthetic Biology (ii) Molecular Microbiology (ii) Industrial Biotechnology and Bioenergy (iv) Food Security (v) Regenerative Medicine (vi) Stem Cell and Developmental Biology (vii) Healthy Aging (viii) Epigenetic Basis of Aging and Disease (ix) Bioscience for Health (x) Systems Biology and Bioinformatics (xi) Exploiting New Ways of Working.The development of an enhanced NGS facility at the UoN alongside the establishment of a regional Midlands Sequencing Consortium will enable the UoN and collaborators to address key biological questions in the above areas which will have a significant impact in science, the economy and society.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s13068-017-0700-9
发表时间: 2017
期刊: Biotechnology for biofuels
影响因子: 6.3
作者: [Daly P, van Munster JM, Blythe MJ, Ibbett R, Kokolski M, Gaddipati S, Lindquist E, Singan VR, Barry KW, Lipzen A, Ngan CY, Petzold CJ, Chan LJG, Pullan ST, Delmas S, Waldron PR, Grigoriev IV, Tucker GA, Simmons BA, Archer DB]
通讯作者: Archer DB
DOI: 10.1186/s13068-015-0410-0
发表时间: 2016
期刊: Biotechnology for biofuels
影响因子: 6.3
作者: [Ehsaan M, Kuit W, Zhang Y, Cartman ST, Heap JT, Winzer K, Minton NP]
通讯作者: Minton NP
DOI: 10.3389/fgene.2017.00068
发表时间: 2017
期刊: Frontiers in genetics
影响因子: 3.7
作者: [Bahbahani H, Tijjani A, Mukasa C, Wragg D, Almathen F, Nash O, Akpa GN, Mbole-Kariuki M, Malla S, Woolhouse M, Sonstegard T, Van Tassell C, Blythe M, Huson H, Hanotte O]
通讯作者: Hanotte O
DOI: 10.1016/j.fgb.2016.04.005
发表时间: 2017-05
期刊: Fungal genetics and biology : FG & B
影响因子: --
作者: [Daly P, van Munster JM, Kokolski M, Sang F, Blythe MJ, Malla S, Velasco de Castro Oliveira J, Goldman GH, Archer DB]
通讯作者: Archer DB
Adaptive sampling ('Read Until') methods in optimised nanopore sequencing technologies
  • 批准号:
    BB/N017099/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $38.36万
  • 财政年份:
    2017
  • 负责人:
    Matthew Loose
  • 依托单位:
Development and applications for long read sequencing in the Midlands
  • 批准号:
    BB/R000492/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $26.78万
  • 财政年份:
    2017
  • 负责人:
    Matthew Loose
  • 依托单位:
minoTour: A real time analysis and data management platform for Oxford Nanopore minION reads.
  • 批准号:
    BB/M020061/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $18.83万
  • 财政年份:
    2015
  • 负责人:
    Matthew Loose
  • 依托单位:
国内基金
海外基金
骨髓来源非CCR2依赖性 Ly6C intermediate 单核细胞向肾脏 Ly6C–CCR2– 巨噬细胞分化——急性肾损伤慢性化的新机制
  • 批准号:
    81974086
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2019
  • 负责人:
    曾锐
  • 依托单位:
INA基因高甲基化释放游离态tubulin促进微管聚合在结直肠癌早期进展中作用及机制研究
  • 批准号:
    31900505
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2019
  • 负责人:
    李英杰
  • 依托单位: